Effectiveness of Ayurvedic Formulation Patanjali Pancogrit in subjects with Chronic Pancreatitis.
Not Applicable
- Conditions
- Health Condition 1: K861- Other chronic pancreatitis
- Registration Number
- CTRI/2023/10/058971
- Lead Sponsor
- Patanjali Research Foundation governed by Patanjali Research Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Subjects with known case of Acute or Chronic Pancreatitis
Male and female of 18 years to 70 years.
Capability of complete compliance and completion of follow-up
Willingness to provide written informed consent.
Exclusion Criteria
Patients with Diabetes or other chronic conditions like chronic kidney disease, Cardiovascular diseases, etc.
Patients consuming drugs like rifampin, lamivudine, octreotide, carbamazepine, etc. which are known to cause pancreatitis.
Pregnant and lactating women and women who intend to become pregnant.
Patient unwilling / not able to give consent.
Any other cause or condition that the investigator may find unfit to be taken for the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluate the symptomatic relief and changes in Quality of life in subjects having acute or chronic pancreatitisTimepoint: Baseline, 3 months, 6 months, 12 months, and 18 months
- Secondary Outcome Measures
Name Time Method Evaluating the changes by using GiQoL Index and PGICin the subjects. Also determine if any damage to the pancreas at 3 and 18 months occur and monitor how this changes throughout the course of study. <br/ ><br>Timepoint: Baseline, 3 months, 6 months, 12 months, and 18 months